Evidence map›Paper›PMID 34214455›Full record

ArticleAmerican journal of ophthalmology2022

Disc Hemorrhages Are Associated With Localized Three-Dimensional Neuroretinal Rim Thickness Progression in Open-Angle Glaucoma.

Milica A Margeta, Kitiya Ratanawongphaibul, Edem Tsikata, Michele Zemplenyi, Courtney L Ondeck, Janice Kim, Anne L Coleman, Fei Yu, Johannes F de Boer, Teresa C Chen

Open access · bronzeAbstract read
In one paragraph

Article in American journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Milica A MargetaFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA.
Kitiya RatanawongphaibulFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA; Glaucoma Research Unit (K.R.), Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Edem TsikataFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA.
Michele ZemplenyiDepartment of Biostatistics (M.Z.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Courtney L OndeckFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA; Department of Ophthalmology (C.L.O.), VA Boston Hospital, Boston, Massachusetts, USA.
Janice KimFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA.
Anne L ColemanDepartment of Ophthalmology (A.L.C., F.Y.), Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA.
Fei YuDepartment of Ophthalmology (A.L.C., F.Y.), Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA; Department of Biostatistics (F.Y.), University of California Los Angeles Fielding School of Public Health, Los Angeles, California, USA.
Johannes F de BoerLaserLaB Amsterdam (J.F.d.B.), Department of Physics and Astronomy, Vrijie Universiteit, Amsterdam, The Netherlands; Department of Ophthalmology, Vrijie Universiteit Medical Center, Amsterdam, The Netherlands.
Teresa C ChenFrom the Department of Ophthalmology (M.A.M, K.R., E.T., C.L.O., TC.C.), Glaucoma Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School (M.A.M., K.R., E.T., C.L.O., J.K., T.C.C.), Boston, Massachusetts, USA. Electronic address: Teresa_Chen@meei.harvard.edu.
Massachusetts Eye and Ear Infirmary · USUniversity of California, Los Angeles · USHarvard University · USVrije Universiteit Amsterdam · NL

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Mass Eye and Ear-Vision Clinical Scientist Development ProgramK12EY016335 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Reza Dana · 2004 to 2026
$12.3M
The Role of APOE Signaling in Microglia in GlaucomaK08EY030160 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI MARGETA, MILICA · 2019 to 2021
$703k
EPA EP-D-15-016NCRR NIH HHS UL1 RR025758NEI NIH HHS K08 EY030160NEI NIH HHS K12 EY016335
6 · The paper itself

Abstract

purposeTo evaluate the relationship between the occurrence of optic disc hemorrhages (DH) and glaucoma progression as determined by multiple glaucoma testing modalities.

designProspective cohort study.

methodsA longitudinal study was undertaken of 124 open-angle glaucoma patients who had yearly disc photography, visual fields (VFs), spectral-domain optical coherence tomography (SD-OCT), retinal nerve fiber layer (RNFL) thickness scans, and optic nerve volume scans (Spectralis), all performed on the same day over a 5-year period. The minimum distance band (MDB) thickness, a 3-dimensional (3D) neuroretinal rim parameter, was calculated from optic nerve volume scans. Patients were classified as glaucoma progressors or glaucoma nonprogressors using event-based analysis.

resultsOf 124 open-angle glaucoma patients, 19 (15.3%) had 1 or more DHs on yearly disc photographs. Presence of a DH was associated with localized 3D neuroretinal rim thickness progression (superior MDB progression; odds ratio: 3.96; P = .04) but not with global or inferior MDB progression (P = .14 and .81, respectively), DP progression (P = .08), VF progression (P = .45), or RNFL global, inferior, or superior progression (P = .17, .26, and .76, respectively). In the majority of patients with MDB progression (14/17 or 82%), the progression was noted before or concurrently with the first instance of DH.

conclusionsGlaucoma progression detected by high-density 3D SD-OCT neuroretinal rim measurements preceded DH occurrence in the majority of patients. These findings support the hypothesis that DHs are indicators of ongoing glaucoma progression rather than discrete events that cause subsequent progression.

Indexed as

Glaucoma, Open-AngleOptic DiskHemorrhageHumansIntraocular PressureLongitudinal StudiesNerve FibersProspective StudiesRetinal Ganglion CellsTomography, Optical Coherence

Identifiers

PMID34214455
PMCPMC8714862
OpenAlexW3175174347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.